ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in April 2020.
A round-up of FDA’s actions in April 2020.
FDA Output April 2020
×
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in April 2020.
A round-up of FDA’s actions in April 2020.